DIACYLGLYCEROL KINASE INHIBITOR I

DIACYLGLYCEROL KINASE INHIBITOR I Suppliers list
Company Name: 3B Pharmachem (Wuhan) International Co.,Ltd.  
Tel: 18930552037
Email: 3bsc@sina.com
Company Name: Nanjing Dulai Biotechnology Co., Ltd.  
Tel: 025-84699383-8003;025-846993838003-8003 18013301590
Email: njduly@126.com
Company Name: Guangzhou Isun Pharmaceutical Co., Ltd  
Tel: 020-39119399 18927568969
Email: isunpharm@qq.com
Company Name: Sigma-Aldrich  
Tel: 021-61415566 800-8193336
Email: orderCN@merckgroup.com
Company Name: EMMX Biotechnology LLC  
Tel: 888-539-0666
Email: info@emmx.com

DIACYLGLYCEROL KINASE INHIBITOR I manufacturers

  • R 59-022
  • R 59-022 pictures
  • $32.00
  • 2026-07-14
  • CAS:93076-89-2
  • Purity: 99.18%
  • Supply Ability: 10g
DIACYLGLYCEROL KINASE INHIBITOR I Basic information
Product Name:DIACYLGLYCEROL KINASE INHIBITOR I
Synonyms:6-[2-[4-[(P-FLUOROPHENYL)PHENYLMETHYLENE]-1-PIPERIDINYL]ETHYL]-7-METHYL-5H-THIAZOLO(3,2-A)PYRIMIDINE-5-ONE;6-[2-[(4-FLUOROPHENYL)PHENYLMETHYLENE]-1-PIPERIDINYL)ETHYL]-7-METHYL-5H-THIAZOLO-[3,2-A]-PYRIMIDIN-5-ONE;6-[2-[4-[(4-FLUOROPHENYL)PHENYLMETHYLENE]-1-PIPERIDINYL]ETHYL]-7-METHYL-5H-THIAZOLO[3,2-A]PYRIMIDIN-5-ONE;DIACYLGLYCEROL KINASE;DIACYLGLYCEROL KINASE INHIBITOR I;DIACYLGLYCEROL KINASE INHIBITOR I (R59 022);DAGK;DAG KINASE
CAS:93076-89-2
MF:C27H26FN3OS
MW:459.58
EINECS:
Product Categories:Lipid signaling
Mol File:93076-89-2.mol
DIACYLGLYCEROL KINASE INHIBITOR I Structure
DIACYLGLYCEROL KINASE INHIBITOR I Chemical Properties
Boiling point 619.8±65.0 °C(Predicted)
density 1.26±0.1 g/cm3(Predicted)
storage temp. -20°C
solubility 0.1 M HCl: slightly soluble
form solid
pka7.76±0.20(Predicted)
color pale yellow
biological sourcesynthetic (organic)
Stability:Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
InChI1S/C27H26FN3OS/c1-19-24(26(32)31-17-18-33-27(31)29-19)13-16-30-14-11-22(12-15-30)25(20-5-3-2-4-6-20)21-7-9-23(28)10-8-21/h2-10,17-18H,11-16H2,1H3
InChIKeyMFVJXLPANKSLLD-UHFFFAOYSA-N
SMILESFc1ccc(cc1)C(=C3CCN(CC3)CCc4[c]([n]5c([s]cc5)nc4C)=O)c2ccccc2
Safety Information
Safety Statements 23-24/25
WGK Germany 3
Storage Class11 - Combustible Solids
MSDS Information
ProviderLanguage
SigmaAldrich English
DIACYLGLYCEROL KINASE INHIBITOR I Usage And Synthesis
DescriptionR-59022 (93076-89-2) is a diacylglycerol kinase (DAGK) inhibitor, nonselective for DAGK isotypes (IC50=2.8 μM in intact platelets).1 Induces autophagy and apoptosis in NG108-15 neuronal cells via an mTOR-independent mechanism.2 Prevents conjugated linoleic acid-mediated inflammatory signaling and insulin resistance in human adipocytes.3 Blocks filovirus internalization in host cells.4
UsesR-59-022 acts as an inducer of apoptosis in glioblastoma cells and avoids apoptosis in non-cancerous cells. This selectivity makes this drug a highly effective anti-cancer agent. Diacylglycerol Kinase inhibitor.
DefinitionChEBI: 6-[2-[4-[(4-fluorophenyl)-phenylmethylidene]-1-piperidinyl]ethyl]-7-methyl-5-thiazolo[3,2-a]pyrimidinone is a diarylmethane.
Biological ActivityDiacylglycerol (DAG) kinase inhibitor (IC 50 = 2.8 μ M); increases protein kinase C activity. Potentiates thrombin-induced platelet aggregation and induces neutrophil chemotaxis. Inhibits U46619-induced contractions in mouse aorta and porcine coronary artery.
in vivo

R 59-022 (2 mg/kg, i.p., 12 days) significantly increases median survival in SCID mice implanted with U87 GBM cells[6].

Animal Model:SCID mice implanted with U87 GBM cells[6]
Dosage:10 mg/kg
Administration:Intraperitoneal injection (i.p.)
Result:Increased median survival and decreased tumor volume.
IC 50PKC; serotonin; diacylglycerol kinase: 2.8 μM (IC50)
References[1] D C DE CHAFFOY DE COURCELLES  H V B  P Roevens. R 59 022, a diacylglycerol kinase inhibitor. Its effect on diacylglycerol and thrombin-induced C kinase activation in the intact platelet.[J]. The Journal of Biological Chemistry, 1985, 260 29: 15762-15770.
[2] TSUYOSHI TAKITA. Diacylglycerol kinase inhibitor R59022-induced autophagy and apoptosis in the neuronal cell line NG108-15[J]. Archives of biochemistry and biophysics, 2011, 509 2: Pages 197-201. DOI:10.1016/j.abb.2011.02.007
[3] KRISTINA MARTINEZ. Diacylglycerol kinase inhibitor R59022 attenuates conjugated linoleic acid-mediated inflammation in human adipocytes.[J]. Journal of Lipid Research, 2013, 54 3: 662-670. DOI:10.1194/jlr.m031211
[4] CORINA M STEWART. A Diacylglycerol Kinase Inhibitor, R-59-022, Blocks Filovirus Internalization in Host Cells.[J]. Viruses-Basel, 2019, 11 3. DOI:10.3390/v11030206
DIACYLGLYCEROL KINASE INHIBITOR I Preparation Products And Raw materials
Tag:DIACYLGLYCEROL KINASE INHIBITOR I(93076-89-2) Related Product Information
2,4-Pentanedione, silver derivative N-Butylisocyanide Methyl isocyanoacetate 1,1,3,3-Tetramethylbutyl isocyanide tert-Butyl isocyanide Phenylselenol SALCOMINE COBALT(II) ACETYLACETONATE Ritanserin Cupric acetylacetonate Aluminum acetylacetonate Tris(2,4-pentanedionato)chroMiuM(III) Benzyl isocyanide Ethyl isocyanoacetate Tosylmethyl isocyanide Dichloro(ethylenediamine)platinum(II) Tris(2,2,6,6-tetramethyl-3,5-heptanedionato)dysprosium(III) Tris(2,2,6,6-tetramethyl-3,5-heptanedionato)europium(III)